GemVax & KAEL Appoints Lee Jae-hong as Chief Medical Officer
Position
Chief Medical Officer
Company
GemVax & KAEL
Description
GemVax & KAEL has hired Lee Jae-hong, a medical doctor and clinical expert in neurodegenerative diseases, as chief medical officer. Lee will oversee clinical development and operations for the company's bio division, enhancing their capabilities in domestic and overseas clinical trials.
Quick answer
GemVax & KAEL Appoints Lee Jae-hong as Chief Medical Officer (November 4, 2026).
- Who is the new Chief Medical Officer at GemVax & KAEL?
- GemVax & KAEL named Lee Jae-hong Chief Medical Officer, announced November 4, 2026.
- What did GemVax & KAEL announce on November 4, 2026?
- GemVax & KAEL has hired Lee Jae-hong, a medical doctor and clinical expert in neurodegenerative diseases, as chief medical officer. Lee will oversee clinical development and operations for the company's bio division, enhancing their capabilities in domestic and overseas clinical trials.
- What does GemVax & KAEL do?
- GemVax & KAEL is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases.
- Which similar companies made leadership changes around the same time?
- Tempest Therapeutics (November 4, 2026), Pfizer (November 3, 2026), AbbVie Inc. (November 2, 2026) and Alnylam Pharmaceuticals (November 5, 2026) also announced leadership changes within 45 days of GemVax & KAEL.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tempest Therapeutics names Stephanie Horn-Warnock CFO, Treasurer, & Corp Sec. (November 4, 2026)
- Pfizer Appoints Cecile Guegan as Chief Financial Officer (November 3, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Alnylam Pharmaceuticals Announces Departure of Executive Vice President (November 5, 2026)
- Oculis Appoints Björn Tackenberg as Chief Scientific Officer (November 2, 2026)
- Apimeds Pharmaceuticals US names Sungjoon Chae Co-Chief Executive Officer (November 6, 2026)
Who to call at GemVax & KAEL, and when
A new leader at GemVax & KAEL brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day GemVax & KAEL raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GemVax & KAEL, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GemVax & KAEL. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GemVax & KAEL changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GemVax & KAEL changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.